AnalysisFeaturesGlobal IssuesHealthMedicineScience, Technology and InnovationSocietyWorld
Moderna follows Pfizer with exciting vaccine news – how to read these dramatic developments
It is very exciting to hear another positive story about vaccine trial results – a good vaccine is the most likely way of ending the pandemic.
Last week, interim results from Pfizer suggested its vaccine reduces cases of COVID-19 with 90% efficacy.
- Simon Kolstoe
- The Conversation
Now Moderna has gone one better, with interim results showing nearly 95% efficacy for its vaccine – with hints that it may protect against severe disease.
Neither have reported any serious safety concerns and have tested their vaccines in tens of thousands of participants.
With so many COVID-19 vaccines in development, more…